Literature DB >> 16273628

Autoimmune hepatitis triggered by acute hepatitis A.

Hiroto Tanaka1, Hiroto Tujioka, Hiroki Ueda, Hiroko Hamagami, Youhei Kida, Masakazu Ichinose.   

Abstract

The patient was a 57-year-old woman presenting with jaundice as the chief complaint. She began vomiting on July 10, 2003. Jaundice was noted and admitted to our hospital for thorough testing. Tests on admission indicated severe hepatitis, based on: aspartate aminotransferase (AST), 1 076 IU/L; alanine aminotransferase (ALT), 1 400 IU/L; total bilirubin (TB), 20.9 mg/dL; and prothrombin time rate (PT%), 46.9%. Acute hepatitis A (HA) was diagnosed based on negative hepatitis B surface antigen and hepatitis C virus RNA and positive immunoglobulin (Ig) M HA antibody, but elevation of anti-nuclear antigen (X320) and IgG (3 112 mg/dL) led to suspicion of autoimmune hepatitis (AIH). Plasma exchange was performed for 3 d from July 17, and steroid pulse therapy was performed for 3 d starting on July 18, followed by oral steroid therapy. Liver biopsy was performed on August 5, and the results confirmed acute hepatitis and mild chronic inflammation. Levels of AST and ALT normalized, so dose of oral steroid was markedly reduced. Steroid therapy was terminated after 4 mo, as the patient had glaucoma. Starting 3 mo after cessation of steroid therapy, levels of AST and ALT began to increase again. Another liver biopsy was performed and AIH was diagnosed based on serum data and biopsy specimen. Oral steroid therapy was reinitiated. Levels of AST and ALT again normalized. The present case was thus considered to represent AIH triggered by acute HA.

Entities:  

Mesh:

Year:  2005        PMID: 16273628      PMCID: PMC4436738          DOI: 10.3748/wjg.v11.i38.6069

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  11 in total

1.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

2.  Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals.

Authors:  S Vento; T Garofano; G Di Perri; L Dolci; E Concia; D Bassetti
Journal:  Lancet       Date:  1991-05-18       Impact factor: 79.321

3.  Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals.

Authors:  S Vento; L Guella; F Mirandola; F Cainelli; G Di Perri; M Solbiati; T Ferraro; E Concia
Journal:  Lancet       Date:  1995-09-02       Impact factor: 79.321

4.  Idiopathic autoimmune chronic hepatitis triggered by hepatitis A.

Authors:  S M Rahaman; P Chira; R S Koff
Journal:  Am J Gastroenterol       Date:  1994-01       Impact factor: 10.864

5.  Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries.

Authors:  G Danan; C Benichou
Journal:  J Clin Epidemiol       Date:  1993-11       Impact factor: 6.437

6.  Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.

Authors:  H F Eggink; H J Houthoff; S Huitema; C H Gips; S Poppema
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

7.  DR human leukocyte antigens and disease severity in chronic hepatitis C.

Authors:  A J Czaja; H Carpenter; P J Santrach; S B Moore
Journal:  J Hepatol       Date:  1996-06       Impact factor: 25.083

8.  Autoimmune chronic active hepatitis developing after acute type B hepatitis.

Authors:  T Laskus; J Slusarczyk
Journal:  Dig Dis Sci       Date:  1989-08       Impact factor: 3.199

Review 9.  [Autoimmune hepatitis caused by acute hepatitis due to hepatitis A virus].

Authors:  E Muñoz Bertrán; V Rosa Salazar; F Hostalet Robles; J A Correa Estañ; G Belda Abad; E Muñoz Ramírez
Journal:  Gastroenterol Hepatol       Date:  2002-10       Impact factor: 2.102

10.  Autoimmune hepatitis following hepatitis A virus infection.

Authors:  H I Huppertz; U Treichel; A M Gassel; R Jeschke; K H Meyer zum Büschenfelde
Journal:  J Hepatol       Date:  1995-08       Impact factor: 25.083

View more
  7 in total

1.  Autoimmune liver disease following acute hepatitis A infection.

Authors:  Hannah Yeend-Curd-Trimble; Kate Kelly; Indrajit Ghosh; Douglas MacDonald
Journal:  BMJ Case Rep       Date:  2019-05-30

Review 2.  Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2015-05-22       Impact factor: 3.199

Review 3.  Acute and acute severe (fulminant) autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-10-23       Impact factor: 3.199

4.  HLA DRB1*13 as a risk factor for type 1 autoimmune hepatitis in North American patients.

Authors:  Albert J Czaja; Herschel A Carpenter; S Breanndan Moore
Journal:  Dig Dis Sci       Date:  2007-05-18       Impact factor: 3.199

Review 5.  Hepatocellular carcinoma in patients with autoimmune hepatitis - a systematic review of the literature published between 1989-2016.

Authors:  Simona Valean; Monica Acalovschi; Dan L Dumitrascu; Lidia Ciobanu; Georgiana Nagy; Romeo Chira
Journal:  Med Pharm Rep       Date:  2019-04-25

6.  Patients with Autoimmune Hepatitis Report Lower Lifetime Coffee Consumption.

Authors:  Craig Lammert; Sai N Chalasani; Kelsey Green; Elizabeth Atkinson; Bryan McCauley; Konstantinos N Lazaridis
Journal:  Dig Dis Sci       Date:  2021-04-30       Impact factor: 3.487

Review 7.  Acute Hepatitis A-Induced Autoimmune Hepatitis: A Case Report and Literature Review.

Authors:  Hye In Jo; Minchang Kim; Jeong-Ju Yoo; Sang Gyune Kim; Young Seok Kim; Susie Chin
Journal:  Medicina (Kaunas)       Date:  2022-06-24       Impact factor: 2.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.